SEC 13F Intelligence

Marshall Wace, LLP / UNH

Marshall Wace, LLP’s Unitedhealth Group Inc Position

Does Marshall Wace, LLP own Unitedhealth Group Inc (UNH)? Yes — 1.41M shares worth $382M (+0.38% of its 13F portfolio) as of Q1 2026, down from 1.70M shares the prior filed quarter.

Position Value
$382M
Q1 2026
Shares
1.41M
% of Portfolio
+0.38%
Quarters Held
28
currently held

Position History UNH

Reported value by quarter
Q4 ’18: $13MQ4 ’18Q1 ’19: $22MQ3 ’19: $8MQ1 ’20: $54MQ2 ’20: $5MQ2 ’20Q3 ’20: $10MQ4 ’20: $21MQ1 ’21: $12MQ2 ’21: $6MQ2 ’21Q3 ’21: $13MQ4 ’21: $433MQ1 ’22: $685MQ2 ’22: $519MQ2 ’22Q3 ’22: $67MQ4 ’22: $3MQ1 ’23: $219MQ2 ’23: $178MQ2 ’23Q3 ’23: $132MQ4 ’23: $131MQ1 ’24: $48MQ2 ’24: $184MQ2 ’24Q3 ’24: $180MQ4 ’24: $989MQ1 ’25: $488MQ2 ’25: $360MQ2 ’25Q3 ’25: $76MQ4 ’25: $563MQ1 ’26: $382Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.41M$382M+0.38%
Q4 20251.70M$563M+0.51%
Q3 2025219.3K$76M+0.08%
Q2 20251.15M$360M+0.41%
Q1 2025931.2K$488M+0.62%
Q4 20241.95M$989M+1.19%
Q3 2024308.7K$180M+0.22%
Q2 2024360.9K$184M+0.25%
Q1 202496.1K$48M+0.07%
Q4 2023248.2K$131M+0.22%
Q3 2023262.3K$132M+0.27%
Q2 2023371.0K$178M+0.35%
Q1 2023463.0K$219M+0.46%
Q4 20225.1K$3M+0.01%
Q3 2022132.3K$67M+0.15%
Q2 20221.01M$519M+1.07%
Q1 20221.34M$685M+1.30%
Q4 2021861.8K$433M+0.80%
Q3 202132.2K$13M+0.05%
Q2 202114.4K$6M+0.03%
Q1 202131.7K$12M+0.05%
Q4 202059.3K$21M+0.11%
Q3 202032.3K$10M+0.06%
Q2 202017.9K$5M+0.04%
Q1 2020216.3K$54M+0.54%
Q3 201938.6K$8M+0.07%
Q1 201990.3K$22M+0.11%
Q4 201850.5K$13M+0.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Marshall Wace, LLP’s full portfolio or all institutional holders of UNH.